These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26946532)

  • 1. Original Research: Generation of non-deletional hereditary persistence of fetal hemoglobin β-globin locus yeast artificial chromosome transgenic mouse models: -175 Black HPFH and -195 Brazilian HPFH.
    Braghini CA; Costa FC; Fedosyuk H; Neades RY; Novikova LV; Parker MP; Winefield RD; Peterson KR
    Exp Biol Med (Maywood); 2016 Apr; 241(7):697-705. PubMed ID: 26946532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. {gamma}-Globin gene expression in chemical inducer of dimerization (CID)-dependent multipotential cells established from human {beta}-globin locus yeast artificial chromosome ({beta}-YAC) transgenic mice.
    Blau CA; Barbas CF; Bomhoff AL; Neades R; Yan J; Navas PA; Peterson KR
    J Biol Chem; 2005 Nov; 280(44):36642-7. PubMed ID: 16131492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mi2β is required for γ-globin gene silencing: temporal assembly of a GATA-1-FOG-1-Mi2 repressor complex in β-YAC transgenic mice.
    Costa FC; Fedosyuk H; Chazelle AM; Neades RY; Peterson KR
    PLoS Genet; 2012; 8(12):e1003155. PubMed ID: 23284307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of yeast artificial chromosomes (YACs) in studies of mammalian development: production of beta-globin locus YAC mice carrying human globin developmental mutants.
    Peterson KR; Li QL; Clegg CH; Furukawa T; Navas PA; Norton EJ; Kimbrough TG; Stamatoyannopoulos G
    Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5655-9. PubMed ID: 7539923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of human gamma-globin gene expression in adult mice carrying a transgene of deletion-type hereditary persistence of fetal hemoglobin.
    Arcasoy MO; Romana M; Fabry ME; Skarpidi E; Nagel RL; Forget BG
    Mol Cell Biol; 1997 Apr; 17(4):2076-89. PubMed ID: 9121456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of human gamma-globin are expressed in adult mice carrying a transgene of the Brazilian type of hereditary persistence of fetal hemoglobin ((A)gamma -195).
    da Cunha AF; Brugnerotto AF; Corat MA; Devlin EE; Gimenes AP; de Melo MB; Passos LA; Bodine D; Saad ST; Costa FF
    Hemoglobin; 2009; 33(6):439-47. PubMed ID: 19958189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin.
    Ravi NS; Wienert B; Wyman SK; Bell HW; George A; Mahalingam G; Vu JT; Prasad K; Bandlamudi BP; Devaraju N; Rajendiran V; Syedbasha N; Pai AA; Nakamura Y; Kurita R; Narayanasamy M; Balasubramanian P; Thangavel S; Marepally S; Velayudhan SR; Srivastava A; DeWitt MA; Crossley M; Corn JE; Mohankumar KM
    Elife; 2022 Feb; 11():. PubMed ID: 35147495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juxtaposition of the HPFH2 enhancer is not sufficient to reactivate the gamma-globin gene in adult erythropoiesis.
    Xiang P; Han H; Barkess G; Olave I; Fang X; Yin W; Stamatoyannopoulos G; Li Q
    Hum Mol Genet; 2005 Oct; 14(20):3047-56. PubMed ID: 16155112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A natural regulatory mutation in the proximal promoter elevates fetal
    Martyn GE; Wienert B; Kurita R; Nakamura Y; Quinlan KGR; Crossley M
    Blood; 2019 Feb; 133(8):852-856. PubMed ID: 30617196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
    Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
    Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental regulation of human gamma- and beta-globin genes in the absence of the locus control region.
    Starck J; Sarkar R; Romana M; Bhargava A; Scarpa AL; Tanaka M; Chamberlain JW; Weissman SM; Forget BG
    Blood; 1994 Sep; 84(5):1656-65. PubMed ID: 7520781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of a region that is a candidate for the difference between the deletion forms of hereditary persistence of fetal hemoglobin and deltabeta-thalassemia affects beta- but not gamma-globin gene expression.
    Calzolari R; McMorrow T; Yannoutsos N; Langeveld A; Grosveld F
    EMBO J; 1999 Feb; 18(4):949-58. PubMed ID: 10022837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequences located 3' to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal A gamma-globin gene in transgenic mice.
    Anagnou NP; Perez-Stable C; Gelinas R; Costantini F; Liapaki K; Constantopoulou M; Kosteas T; Moschonas NK; Stamatoyannopoulos G
    J Biol Chem; 1995 Apr; 270(17):10256-63. PubMed ID: 7537267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G gamma A gamma (beta+) hereditary persistence of fetal hemoglobin: the G gamma -158 C-->T mutation in cis to the -175 T-->C mutation of the A gamma-globin gene results in increased G gamma-globin synthesis.
    Coleman MB; Adams JG; Steinberg MH; Plonczynski MW; Harrell AH; Castro O; Winter WP
    Am J Hematol; 1993 Feb; 42(2):186-90. PubMed ID: 7679879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T to C substitution at -175 or -173 of the gamma-globin promoter affects GATA-1 and Oct-1 binding in vitro differently but can independently reproduce the hereditary persistence of fetal hemoglobin phenotype in transgenic mice.
    Liu LR; Du ZW; Zhao HL; Liu XL; Huang XD; Shen J; Ju LM; Fang FD; Zhang JW
    J Biol Chem; 2005 Mar; 280(9):7452-9. PubMed ID: 15613485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the beta-like globin genes in transgenic mice is dependent on the presence of the beta-locus control region.
    Navas PA; Li Q; Peterson KR; Swank RA; Rohde A; Roy J; Stamatoyannopoulos G
    Hum Mol Genet; 2002 Apr; 11(8):893-903. PubMed ID: 11971871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition.
    Traxler EA; Yao Y; Wang YD; Woodard KJ; Kurita R; Nakamura Y; Hughes JR; Hardison RC; Blobel GA; Li C; Weiss MJ
    Nat Med; 2016 Sep; 22(9):987-90. PubMed ID: 27525524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disrupting the adult globin promoter alleviates promoter competition and reactivates fetal globin gene expression.
    Topfer SK; Feng R; Huang P; Ly LC; Martyn GE; Blobel GA; Weiss MJ; Quinlan KGR; Crossley M
    Blood; 2022 Apr; 139(14):2107-2118. PubMed ID: 35090172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fetal globin gene mutation in A gamma nondeletion hereditary persistence of fetal hemoglobin increases promoter strength in a nonerythroid cell.
    Rixon MW; Gelinas RE
    Mol Cell Biol; 1988 Feb; 8(2):713-21. PubMed ID: 2451123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single point mutation is the cause of the Greek form of hereditary persistence of fetal haemoglobin.
    Berry M; Grosveld F; Dillon N
    Nature; 1992 Aug; 358(6386):499-502. PubMed ID: 1379347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.